Characteristics and outcomes associated with CD2 and CD25 expression on bone marrow mast cells in patients with systemic mastocytosis.

Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
29 Aug 2024
Historique:
received: 22 04 2024
medline: 2 9 2024
pubmed: 2 9 2024
entrez: 2 9 2024
Statut: aheadofprint

Résumé

Not available.

Identifiants

DOI: 10.3324/haematol.2024.285740 PMID: 39219498
pubmed: 39219498
doi: 10.3324/haematol.2024.285740
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Julien Rossignol (J)

CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.

Sophie Georgin-Lavialle (S)

Department of Internal Medicine, Tenon Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Sorbonne Université, Paris.

Danielle Canioni (D)

CEREMAST, Department of Pathology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris.

Omer Beganovic (O)

Université Paris Cité, INSERM UMR-S1151, CNRS UMR-S8253, Institut Necker Enfants Malades, F-75015 Paris, France; Hôpital Necker Enfants-Malades, Laboratoire d'Onco-Hématologie, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris.

Chantal Brouzes (C)

Université Paris Cité, INSERM UMR-S1151, CNRS UMR-S8253, Institut Necker Enfants Malades, F-75015 Paris, France; Hôpital Necker Enfants-Malades, Laboratoire d'Onco-Hématologie, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris.

Olivier Fain (O)

Department of Internal Medicine, Sorbonne University, Saint-Antoine Hospital, AP-HP, Paris.

Maël Heiblig (M)

CEREMAST, Department of Hematology, Lyon-Sud Hospital, Hospices Civils de Lyon, Pierre-Bénite.

Clément Gourguechon (C)

Department of Hematology, Amiens University Hospital, Amiens.

Philippe Guilpain (P)

CEREMAST, Department of Internal Medicine-Multi-organ Diseases, Saint-Eloi University Hospital, Montpellier University, Montpellier.

Cristina Bulai-Livideanu (C)

CEREMAST, Department of Dermatology, Hôpital Larrey, CHU Toulouse, Toulouse.

Stéphane Barete (S)

CEREMAST, Dermatology Department, Pitié-Salpêtrière Hospital, AP-HP, Paris.

Julie Agopian (J)

Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Marseille.

Fabienne Brenet (F)

Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Marseille.

Patrice Dubreuil (P)

Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Marseille.

Richard Lemal (R)

CEREMAST, Adult Clinical Hematology, CHU Clermont-Ferrand, INSERM CIC501, EA 7453 - Clermont Auvergne University, Clermont-Ferrand.

Olivier Tournilhac (O)

CEREMAST, Adult Clinical Hematology, CHU Clermont-Ferrand, INSERM CIC501, EA 7453 - Clermont Auvergne University, Clermont-Ferrand.

Louis Terriou (L)

CEREMAST, Department of Internal Medicine and Clinical Immunology, Claude Huriez hospital, CHRU Lille, Lille.

David Launay (D)

CEREMAST, Department of Internal Medicine and Clinical Immunology, Claude Huriez hospital, CHRU Lille, Lille, France; Lille University, INSERM U995 LIRIC, CHU Lille, and Referral Center for Rare Systemic Autoimmune Diseases North and North-West of France, Lille.

Laurence Bouillet (L)

CEREMAST, Clinical Immunology/Internal Medicine Department, National Reference Center for Angioedema, Grenoble University Hospital, Grenoble.

Catharina Chatain (C)

CEREMAST, Clinical Immunology/Internal Medicine Department, National Reference Center for Angioedema, Grenoble University Hospital, Grenoble.

Ghandi Damaj (G)

CEREMAST, Hematology Institute, Normandy University School of Medicine, Caen.

Thomas Ballul (T)

CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.

Celine Greco (C)

CEREMAST, Department of Pain and Palliative Care Unit, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris.

Laura Polivka (L)

CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris, France; Department of Dermatology, Reference Center for Genodermatoses (MAGEC), AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.

Laurent Frenzel (L)

CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.

Cécile Meni (C)

CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.

Hassiba Bouktit (H)

CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.

Dina Benabou (D)

CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.

Clotilde Devin (C)

CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.

Caroline Gaudy-Marqueste (C)

CEREMAST, Department of Dermatology, Aix-Marseille University, CHU Timone, Marseille.

Marie Gousseff (M)

Department of Internal Medicine, Centre Hospitalier Bretagne Atlantique, Vannes.

Edwige Le Mouel (E)

CEREMAST, Department of Internal Medicine and Clinical Immunology, Rennes University Hospital, Rennes.

Antoine Neel (A)

CEREMAST, Department of Internal Medicine, Hôtel-Dieu University Hospital, Nantes.

Dana Ranta (D)

Department of Hematology, Nancy University Hospital, Nancy.

Roland Jaussaud (R)

Department of Internal Medicine and Clinical Immunology, Vandoeuvre-lès-Nancy.

Thierry Jo Molina (T)

CEREMAST, Department of Pathology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris.

Julie Bruneau (J)

CEREMAST, Department of Pathology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris.

Rose-Marie Javier (RM)

CEREMAST, Department of Rheumatology, Strasbourg University Hospital, Strasbourg.

Fabien Pelletier (F)

CEREMAST, Department of Dermatology, Allergology Unit, University Hospital of Besançon, Besançon.

Florence Castelain (F)

CEREMAST, Department of Dermatology, Allergology Unit, University Hospital of Besançon, Besançon.

Frederique Retornaz (F)

Unité de soins et de recherche en médecine interne et maladies infectieuses, European hospital, Marseille.

Quentin Cabrera (Q)

Department of Hematology, Sud Reunion University Hospital, Saint Pierre, La Réunion.

Patricia Zunic (P)

Department of Hematology, Sud Reunion University Hospital, Saint Pierre, La Réunion.

Marie Pierre Gourin (MP)

CEREMAST, Department of Hematology, CHU Dupuytren, Limoges.

Ewa Wierzbicka-Hainaut (E)

CEREMAST, Department of Dermatology, CHU de Poitiers, Poitiers.

Jean François Viallard (JF)

Department of Internal Medicine and Infectious Diseases, Haut-Lévêque Hospital, CHRU Bordeaux; Bordeaux University, Bordeaux.

Christian Lavigne (C)

CEREMAST, Department of Internal Medicine and Clinical Immunology, University Hospital, Angers.

Cyrille Hoarau (C)

CEREMAST, Department of Clinical Immunology and Allergology, CHRU Tours, Tours.

Isabelle Durieu (I)

CEREMAST, Department of Internal Medicine, Adult Cystic Fibrosis Care Center, Hospices Civils de Lyon, Lyon.

Sophie Dimicoli-Salazar (S)

Department of Hematology, CHU Bordeaux, Bordeaux.

Jose Miguel Torregrosa-Diaz (JM)

Department of Hematology, CHU Poitiers, Poitiers.

Audrey Duval (A)

Paris Centre University, Imagine Institute, Data Science Platform, INSERM UMR 1163, F-75015, Paris.

Nicolas Garcelon (N)

Paris Centre University, Imagine Institute, Data Science Platform, INSERM UMR 1163, F-75015, Paris.

Jeremie Lespinasse (J)

eXYSTAT, Malakoff.

Angèle Soria (A)

CEREMAST, Department of Dermatology and Allergy, Tenon Hospital, Sorbonne University, Paris.

Yannick Chantran (Y)

CEREMAST, Department of Biological Immunology, Saint-Antoine Hospital, Sorbonne University, Paris.

Michel Arock (M)

CEREMAST, Laboratory of Hematology, Pitié-Salpêtrière Hospital, AP-HP, Paris Sorbonne University.

Christine Bodemer (C)

CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris, France; Department of Dermatology, Reference Center for Genodermatoses (MAGEC), AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.

Olivier Lortholary (O)

CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.

Vahid Asnafi (V)

Université Paris Cité, INSERM UMR-S1151, CNRS UMR-S8253, Institut Necker Enfants Malades, F-75015 Paris, France; Hôpital Necker Enfants-Malades, Laboratoire d'Onco-Hématologie, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris.

Olivier Hermine (O)

CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.

Ludovic Lhermitte (L)

Université Paris Cité, INSERM UMR-S1151, CNRS UMR-S8253, Institut Necker Enfants Malades, F-75015 Paris, France; Hôpital Necker Enfants-Malades, Laboratoire d'Onco-Hématologie, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris. ludovic.lhermitte@aphp.fr.

Classifications MeSH